"Anti-Retroviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used to treat RETROVIRIDAE INFECTIONS.
| Descriptor ID |
D044966
|
| MeSH Number(s) |
D27.505.954.122.388.077
|
| Concept/Terms |
Anti-Retroviral Agents- Anti-Retroviral Agents
- Agents, Anti-Retroviral
- Anti Retroviral Agents
- Antiretroviral Agents
- Agents, Antiretroviral
|
Below are MeSH descriptors whose meaning is more general than "Anti-Retroviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Retroviral Agents".
This graph shows the total number of publications written about "Anti-Retroviral Agents" by people in this website by year, and whether "Anti-Retroviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 2 | 0 | 2 |
| 2004 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 4 | 4 |
| 2018 | 1 | 2 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 0 | 2 | 2 |
| 2022 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Retroviral Agents" by people in Profiles.
-
"When you have an immune disease like HIV and there is a pandemic, you still have to pay your bills": COVID-19-related challenges among people living with HIV and lessons for care delivery. AIDS Care. 2022 11; 34(11):1405-1412.
-
Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model. J Clin Invest. 2022 02 01; 132(3).
-
Alveolar macrophages from persons living with HIV show impaired epigenetic response to Mycobacterium tuberculosis. J Clin Invest. 2021 11 15; 131(22).
-
Pharmacokinetics and safety of maraviroc in neonates. AIDS. 2021 03 01; 35(3):419-427.
-
Patterns of Exposure to Socio-structural Stressors and HIV Care Engagement Among Transgender Women of Color. AIDS Behav. 2020 Nov; 24(11):3155-3163.
-
Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model. J Clin Invest. 2020 10 01; 130(10):5171-5179.
-
HIV stigma and viral load among African-American women receiving treatment for HIV. AIDS. 2019 07 15; 33(9):1511-1519.
-
Care continuum entry interventions: seek and test strategies to engage persons most impacted by HIV within the United States. AIDS. 2018 02 20; 32(4):407-417.
-
"These African stories": Life, labor, and dying in northern Zambia. Soc Sci Med. 2018 03; 201:9-17.
-
Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth. Antivir Ther. 2018; 23(4):315-324.